255 related articles for article (PubMed ID: 8732493)
1. Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects.
Naoumova RP; Cummings MH; Watts GF; Rendell NB; Taylor GW; Sönksen PH; Thompson GR
Eur J Clin Invest; 1996 Apr; 26(4):332-40. PubMed ID: 8732493
[TBL] [Abstract][Full Text] [Related]
2. Effects of insulin on cholesterol synthesis in type II diabetes patients.
Scoppola A; Testa G; Frontoni S; Maddaloni E; Gambardella S; Menzinger G; Lala A
Diabetes Care; 1995 Oct; 18(10):1362-9. PubMed ID: 8721938
[TBL] [Abstract][Full Text] [Related]
3. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Naoumova R; Slavin BM; Thompson GR; Sönksen PH
Diabetologia; 1995 Aug; 38(8):959-67. PubMed ID: 7589883
[TBL] [Abstract][Full Text] [Related]
4. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
Malmström R; Packard CJ; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen MR
Diabetologia; 1997 Apr; 40(4):454-62. PubMed ID: 9112023
[TBL] [Abstract][Full Text] [Related]
5. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
[TBL] [Abstract][Full Text] [Related]
6. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
7. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Kelly JM; Jackson NC; Sönksen PH
Diabetes; 1995 Sep; 44(9):1059-65. PubMed ID: 7657029
[TBL] [Abstract][Full Text] [Related]
8. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
Vaag A; Alford F; Beck-Nielsen H
Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular triglyceride content is increased in IDDM.
Ebeling P; Essén-Gustavsson B; Tuominen JA; Koivisto VA
Diabetologia; 1998 Jan; 41(1):111-5. PubMed ID: 9498639
[TBL] [Abstract][Full Text] [Related]
10. Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).
Vaag A; Lehtovirta M; Thye-Rönn P; Groop L;
Diabet Med; 2001 Jul; 18(7):533-40. PubMed ID: 11553181
[TBL] [Abstract][Full Text] [Related]
11. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
Cusi K; Cunningham GR; Comstock JP
Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
[TBL] [Abstract][Full Text] [Related]
13. UK Prospective Diabetes Study (UKPDS). XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects.
Diabet Med; 1994 Jul; 11(6):534-44. PubMed ID: 7955969
[TBL] [Abstract][Full Text] [Related]
14. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.
Miyazaki Y; Mahankali A; Matsuda M; Glass L; Mahankali S; Ferrannini E; Cusi K; Mandarino LJ; DeFronzo RA
Diabetes Care; 2001 Apr; 24(4):710-9. PubMed ID: 11315836
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
[TBL] [Abstract][Full Text] [Related]
16. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-IV levels and phenotype distribution in NIDDM.
Vergès BL; Vaillant G; Goux A; Lagrost L; Brun JM; Gambert P
Diabetes Care; 1994 Aug; 17(8):810-7. PubMed ID: 7956623
[TBL] [Abstract][Full Text] [Related]
18. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
[TBL] [Abstract][Full Text] [Related]
19. Plasma cholesteryl ester transfer and hepatic lipase activity are related to high-density lipoprotein cholesterol in association with insulin resistance in type 2 diabetic and non-diabetic subjects.
Riemens SC; van Tol A; Scheek LM; Dullaart RP
Scand J Clin Lab Invest; 2001 Feb; 61(1):1-9. PubMed ID: 11300605
[TBL] [Abstract][Full Text] [Related]
20. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
Vaag A; Henriksen JE; Madsbad S; Holm N; Beck-Nielsen H
J Clin Invest; 1995 Feb; 95(2):690-8. PubMed ID: 7860750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
